Skip to Main Content

Author Details

Todd D Prickett
National Cancer Institute
2000
53
35
PMIDPaper TitleJournal TitlePublished Year
37368077Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens.Cancer Immunol Immunother2023
37368077Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens.Cancer Immunol Immunother2023
37045473Specific recognition of an <i>FGFR2</i> fusion by tumor infiltrating lymphocytes from a patient with metastatic cholangiocarcinoma.J Immunother Cancer2023
37045473Specific recognition of an <i>FGFR2</i> fusion by tumor infiltrating lymphocytes from a patient with metastatic cholangiocarcinoma.J Immunother Cancer2023
35104158Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes.J Clin Oncol2022
35452604A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers.Cancer Cell2022
36007524Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade.Med2022
35749374Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.Cancer Immunol Res2022
35247926Neoantigen Identification and Response to Adoptive Cell Transfer in Anti-PD-1 Naïve and Experienced Patients with Metastatic Melanoma.Clin Cancer Res2022
35113651Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers.Science2022
35104158Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes.J Clin Oncol2022
35452604A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers.Cancer Cell2022
35749374Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.Cancer Immunol Res2022
36007524Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade.Med2022
35247926Neoantigen Identification and Response to Adoptive Cell Transfer in Anti-PD-1 Naïve and Experienced Patients with Metastatic Melanoma.Clin Cancer Res2022
35113651Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers.Science2022
34266885Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma.J Immunother Cancer2021
34266885Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma.J Immunother Cancer2021
34321276Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing.J Immunother Cancer2021
34927080A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor types.Nat Cancer2021
34927080A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor types.Nat Cancer2021
34321276Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing.J Immunother Cancer2021
33016924mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer.J Clin Invest2020
33016924mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer.J Clin Invest2020
30683863Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients.Nat Commun2019
31609250Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes.J Clin Invest2019
31036766Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer.J Immunol2019
30683863Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients.Nat Commun2019
31164343Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers.Cancer Discov2019
30709841Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer.Cancer Immunol Res2019
31609250Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes.J Clin Invest2019
30709841Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer.Cancer Immunol Res2019
31036766Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer.J Immunol2019
31164343Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers.Cancer Discov2019
29174843An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors.Mol Ther2018
29867227Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer.Nat Med2018
30282837Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy.JCI Insight2018
29853601T-cell Responses to TP53 "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers.Clin Cancer Res2018
29174843An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors.Mol Ther2018
29867227Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer.Nat Med2018
29853601T-cell Responses to TP53 "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers.Clin Cancer Res2018
30282837Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy.JCI Insight2018
27827318Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.Clin Cancer Res2017
28986867Genetic and Functional Analysis of GRIN2A in Tumor Samples.Methods Mol Biol2017
28377481Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer.Clin Cancer Res2017
28408606Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.Science2017
27827318Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.Clin Cancer Res2017
28408606Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.Science2017
28377481Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer.Clin Cancer Res2017
28986867Genetic and Functional Analysis of GRIN2A in Tumor Samples.Methods Mol Biol2017
  • 1 - 50 of 106

Recommended Authors

Brian J Capaldo
Center for Cancer Research, National Cancer Institute
Career Start Year 2012
Number of shared co-authors 0
Mitchell P Levesque
University Hospital Zurich
Career Start Year 2009
Number of shared co-authors 7
Phil F Cheng
University Hospital of Zurich
Career Start Year 2007
Number of shared co-authors 8
Lawrence N Kwong
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 3
Riyue Bao
UPMC Hillman Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Yongmei Feng
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2002
Number of shared co-authors 5
Sophia Derdak
Medical University of Vienna
Career Start Year 2001
Number of shared co-authors 1
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 3
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 0
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 5
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 0
Andrey Loboda
Merck & Co., Inc.
Career Start Year 1998
Number of shared co-authors 2
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 2
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 5
Andrew E Aplin
Thomas Jefferson University
Career Start Year 1996
Number of shared co-authors 5
Yi-Mi Wu
University of Michigan Medical School ann arbor
Career Start Year 1995
Number of shared co-authors 0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Timothy A Chan
Cleveland Clinic.
Career Start Year 1994
Number of shared co-authors 3
Marcus Bosenberg
Yale School of Medicine
Career Start Year 1992
Number of shared co-authors 14
Levi A Garraway
Broad Institute of Harvard and MIT
Career Start Year 1991
Number of shared co-authors 5
Glenn S Cowley
Broad Institute of Harvard and MIT
Career Start Year 1990
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 4
David E Fisher
Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School
Career Start Year 1983
Number of shared co-authors 9
Dave S B Hoon
Saint John's Cancer Institute at Saint John's Health Center
Career Start Year 1982
Number of shared co-authors 7
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1981
Number of shared co-authors 10
David J Adams
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 6
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 0
Alexander Kamb
Inc. 30301 Agoura Rd.
Career Start Year 1979
Number of shared co-authors 0
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 8

Collaborators

Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 39
Jared J Gartner
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 35
Yardena Samuels
Weizmann Institute of Science
Co-authored papers 12
Satyajit Ray
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 9
Jimmy C Lin
National Human Genome Research Institute, US National Institutes of Health
Co-authored papers 9
Xiaomu Wei
Cornell University
Co-authored papers 8
David L Brautigan
Co-authored papers 8
John R Wunderlich
National Cancer Institute
Co-authored papers 8
Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Jeffrey E Gershenwald
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 4
Neena S Agrawal
Co-authored papers 3
Julia C Cronin
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 3
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 3
Alfredo A Molinolo
University of California
Co-authored papers 3
Susan R Davis
Co-authored papers 3
Vijay Walia
National Center for Toxicological Research
Co-authored papers 3
Elliott H Margulies
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 3
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 3
Steven E Robinson
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Stephen C J Parker
University of Michigan ann arbor
Co-authored papers 2
Cuong Hoang-Vu
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Nicholas K Hayward
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Carolyn E Banister
University of South Carolina
Co-authored papers 2
Ken Dutton-Regester
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Co-authored papers 2
Guo Chen
China Pharmaceutical University
Co-authored papers 2
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Allison S Burrell
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Phillip Buckhaults
University of South Carolina
Co-authored papers 2
Release 1.2